Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
61,922
-
Shares change
-
+15,614
-
Total reported value, excl. options
-
$460,755
-
Value change
-
+$115,166
-
Number of buys
-
8
-
Number of sells
-
6
-
Price
-
$7.39
Institutional Holders of MiNK Therapeutics, Inc. - COM NEW (INKT) as of Q2 2025
As of 30 Jun 2025 MiNK Therapeutics, Inc. - COM NEW (INKT) had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 61,922 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, Longbow Finance SA, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, TOTAL INVESTMENT MANAGEMENT INC, UBS Group AG, Covestor Ltd, and OSAIC HOLDINGS, INC..
This table shows 20 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.